Fractionation of human lymphocytes with plant lectins. III. Identification of cells regulating the in vitro response to L-phytohaemagglutinin. 1980

D H Boldt, and R D Lyons

Peripheral blood lymphocytes (PBL) were separated into two subclasses by differential adherence to wheat germ agglutinin (WGA). WGA-adherent PBL differed structurally (different WGA-binding properties) and functionally from WGA-non-adherent cells. As judged by [3H]-thymidine incorporation, WGA-adherent PBL responded less well to L-phytohaemagglutinin (L-PHA) than non-adherent cells. This difference was not due to different L-PHA dose requirements or different response kinetics. WGA-adherent and non-adherent PBL bound identical amounts of 125I-L-PHA and contained comparable percentages of T cells, B cells, and monocytes. Addition of mitomycin-C-pre-treated WGA-adherent cells to non-adherent cells caused suppression of the L-PHA response. Maximal suppression occurred at a ratio of 1 adherent:2 non-adherent cells and on days 5-7 of culture. Under these conditions the adherent cells themselves did not proliferate indicating that active proliferation was not required for inhibition. Suppression was selective for L-PHA as it did not occur in cultures stimulated with concanavalin A, pokeweed mitogen, Lens culinaris lectin, or in the mixed leucocyte reaction. Cell fractionation techniques indicated that plastic adherent cells (presumably monocytes) in the WGA-adherent subclass were critical for mediation of suppression; These data provide evidence for a specific human suppressor cell of the in vitro response to L-PHA.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D037102 Lectins Proteins that share the common characteristic of binding to carbohydrates. Some ANTIBODIES and carbohydrate-metabolizing proteins (ENZYMES) also bind to carbohydrates, however they are not considered lectins. PLANT LECTINS are carbohydrate-binding proteins that have been primarily identified by their hemagglutinating activity (HEMAGGLUTININS). However, a variety of lectins occur in animal species where they serve diverse array of functions through specific carbohydrate recognition. Animal Lectin,Animal Lectins,Isolectins,Lectin,Isolectin,Lectin, Animal,Lectins, Animal

Related Publications

D H Boldt, and R D Lyons
March 1974, Clinical and experimental immunology,
D H Boldt, and R D Lyons
June 1977, Acta radiologica: therapy, physics, biology,
D H Boldt, and R D Lyons
November 1976, British journal of obstetrics and gynaecology,
D H Boldt, and R D Lyons
June 1976, British journal of obstetrics and gynaecology,
D H Boldt, and R D Lyons
December 1983, Revista espanola de fisiologia,
D H Boldt, and R D Lyons
July 1989, Journal of immunological methods,
D H Boldt, and R D Lyons
June 1991, Clinical science (London, England : 1979),
Copied contents to your clipboard!